Skip to main content
SpringerLink
Log in

Charting a course through a perfect storm

  • Commentary
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A venture capitalist gives his perspective on the outlook for life sciences ventures amid the perfect storm of the current economic downturn.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Ebb and flow of biotech mergers & acquisitions.

Author information

Authors and Affiliations

  1. Arthur Klausner is at Pappas Ventures, 2520 Meridian Parkway, Suite 400, Durham, North Carolina 27713, USA. aklausner@pappasventures.com.,

    Arthur Klausner

Authors
  1. Arthur Klausner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klausner, A. Charting a course through a perfect storm. Nat Biotechnol 27, 125–127 (2009). https://doi.org/10.1038/nbt0209-125

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0209-125

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation